Bladder Cancer

Posted On 2020-06-08 03:08:43

Urinary bladder cancer (BCa) accounts for about 7% of all new cancers in the United States with 81,190 estimated new cases and 17,240 deaths in 2018. Approximately 75% of the new diagnoses BCa will be non-muscle-invasive BCa (NMIBC) affected by recurrence and progression rates of approximately 60% and 20%, respectively. Several unmet questions have been raised in the urological community regarding BCa. In this series on BCa we collected a series of articles treating some of the most important issue for the urological community.

Present and future perspective in the field of bladder cancer
Marco Moschini

Review Article
Role and efficacy of current biomarkers in bladder cancer
Andrea Giordano, Francesco Soria

Therapeutic management of Bacillus Calmette–Guerin refractory patients: a narrative review
Judith Stangl-Kremser, Kilian M. Gust, Shahrokh F. Shariat

Enhanced recovery after surgery (ERAS) in patients treated with radical cystectomy
Wojciech Krajewski, Romuald Zdrojowy

Indication and prognostic value of second transurethral resection in bladder cancer patients
Pietro Grande, Thomas Seisen, Morgan Roupret

Timing of treatment for muscle-invasive bladder cancer in the neo-adjuvant chemotherapy era
Giovanni Motterle, R. Jeffrey Karnes

The impact of histological variants on bladder cancer outcomes
Tania Processali, Alberto Diminutto, Maria Angela Cerruto, Alessandro Antonelli

Bladder preservation therapy in muscle-invasive bladder cancer: Current evidence and future perspectives
Hajime Tanaka, Toshiki Kijima, Yasuhisa Fujii

The impact of robotic surgery in bladder cancer patients
Francesco Greco, Nicola Pesenti, Alberto Vismara, Lorenzo Tessa, Rocca Lisanti, Luigi Domanico, Riccardo Farci, Emanuele Micheli, Vincenzo Maria Altieri

The effect of perioperative blood transfusion on oncological outcomes in radical cystectomy patients: a narrative review
Stefania Zamboni, Chiara Lonati, Carlotta Palumbo, Maria Cristina Marconi, Francesca Mondini, Marco Lattarulo, Marco Moschini, Luca Cristinelli, Sandra Belotti, Claudio Simeone

The impact of transurethral en bloc resection of bladder tumour on pathological and oncological outcomes
Vinson Wai-Shun Chan, Chi-Fai Ng, Jeremy Yuen-Chun Teoh

Editorial Commentary
Lymph node dissection during radical cystectomy: indications, extension and impact on survival outcomes
Riccardo Mastroianni, Gabriele Tuderti, Giuseppe Simone

The series “Bladder Cancer” was commissioned by the editorial office, AME Medical Journal without any sponsorship or funding. Marco Moschini served as the unpaid Guest Editor for the series.